More Press Releases

View Older Stories View Newer Stories

Oct 25, 2026 11:52AM Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
Oct 25, 2026 11:35AM Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
Oct 25, 2026 11:31AM Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 202
Oct 25, 2026 11:28AM Crypto News: Oil Ends the Week Near $117 as Bitcoin Holds Around $80K and Remittix Plans a 300M RTX Burn
Oct 25, 2026 11:30AM TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
Oct 25, 2026 11:30AM In HelloNation, Insulation Expert Mike Mancuso Explains Why Air Sealing Should Come Before Adding Insulation
Oct 25, 2026 11:30AM Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
Oct 25, 2026 11:30AM Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Oct 25, 2026 11:15AM Polygon Price Prediction: German Savings Banks Add POL as Remittix Plans 41 More Fiat Currencies
Oct 25, 2026 11:00AM HBAR Price Prediction: Hedera Joins Five Groups Pressing SEC as Remittix Earn Readies Morpho, Fluid and Maple Finance Pools
Oct 25, 2026 10:45AM Best Crypto Presale 2026: JPMorgan Adds Two Funds to Solana as Remittix Recruits 100 Earn Testers
Oct 25, 2026 10:42AM The Exhibition Hall of Achievements of China's Language Resources Protection Project Officially Opens
Oct 25, 2026 10:37AM Best Altcoin to Buy: $134B Left Altcoins, Yet Pepeto Buyers Keep Coming as NEAR and QNT Wait
Oct 25, 2026 10:36AM Crypto News Today: $431M Shaken Out as ETH and XRP Reset, While Cofounder Builds Pepeto
Oct 25, 2026 10:28AM Crypto Update: Ethereum’s Four-Minute Settlement Proposal Meets Remittix Earn’s 18-22% APY Test Offer
Oct 25, 2026 10:15AM Chainlink Price Prediction: LINK Near $11.30 After LG CNS Deal as Remittix Earn Readies Aave, Morpho and Fluid Pools
Oct 25, 2026 10:00AM Litecoin Price Prediction: Can LTC Reclaim $63 as Remittix Plans a 64.3% Presale Price Increase?
Oct 25, 2026 09:45AM SOL, ETH and Remittix: Best Crypto Presale to Buy as Earn Prepares Aave, Morpho and Fluid Pools?
Oct 25, 2026 09:28AM Crypto News: Bitcoin and XRP Face Oil’s $117 Close as Remittix Invites Earn Testers With Weekly Payouts
Oct 25, 2026 09:15AM Bitcoin News: Tesla-SpaceX Merger Talks Put Their BTC Holdings in Focus as Remittix Plans a 300M RTX Burn
Oct 25, 2026 10:29AM Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
Oct 25, 2026 10:29AM Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform
Oct 25, 2026 10:10AM Nekteck Makes Everyday Relaxation and Recovery More Accessible With Practical Wellness Products
Oct 25, 2026 09:50AM Crypto News: Remittix Announces 300 Million RTX Burn at Launch as JPMorgan Brings Two Tokenized Funds to Solana, Building the Case for a $300 SOL Price Prediction
Oct 25, 2026 09:45AM RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
Oct 25, 2026 09:32AM LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026
Oct 25, 2026 09:00AM Ethereum Price Prediction: ETH Near $2,324 as Four-Minute Proposal Meets Remittix’s 100-Tester Earn Offer
Oct 25, 2026 08:45AM Crypto News Today: Swiss Retail Bitcoin ETF Approval Meets Remittix’s $0.28 Entry and November Launch Countdown
Oct 25, 2026 09:00AM Dr. Anna Nolin Highlights Human-Centered Leadership as Schools Navigate the Next Phase of Artificial Intelligence
Oct 25, 2026 09:00AM ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
Oct 25, 2026 08:36AM Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration
Oct 25, 2026 08:28AM Bitcoin Price News: ETFs Added $1B Earlier This Week as Remittix Recruits 100 Earn Testers
Oct 25, 2026 08:15AM XRP Price Today: XRP Near $1.29 as Wallets Hit 8.24M and Remittix Prepares a 20% Supply Cut
Oct 25, 2026 08:00AM New Crypto Watch: Monero Gains Around 2% as Remittix’s $33M Raise Meets a Planned 300M RTX Burn
Oct 25, 2026 07:45AM Binance New Listing Watch: Alpha Removes Seven Tokens as Remittix Prepares Its November 24 Debut
Oct 25, 2026 08:11AM Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati
Oct 25, 2026 08:00AM Come Back to Firefox: Mozilla launches its most ambitious campaign yet to bring people back to the independent alternative to big tech browsers
Oct 25, 2026 07:34AM TRON Price Prediction: $23M Revenue Report Beats ETH and SOL Combined as Remittix Plans 41 More Fiat Currencies
Oct 25, 2026 07:27AM AirTripMaker Launches Comprehensive Flight Tickets to India Routes Guide from the USA and Canada to Major Indian Destinations
Oct 25, 2026 07:01AM Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
Oct 25, 2026 07:00AM Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
Oct 25, 2026 07:00AM Beyond GRC: DigitalXForce Pioneers AI-Powered Risk Operations with Global X-ROC™ Rollout
Oct 25, 2026 07:00AM NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
Oct 25, 2026 07:00AM Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Oct 25, 2026 07:53AM Binance Acquires BTEXCHAIN, Accelerating the Integration of AI and Global Digital Asset Trading Technology
Oct 25, 2026 06:37AM The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
Oct 25, 2026 06:30AM Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers
Oct 25, 2026 06:26AM Beyond Live Streaming: Tango Gives Back by Supporting Cancer Detection in Ukraine
Oct 25, 2026 06:22AM Borr Drilling Limited - Prospector 5 Rig Incident
Oct 25, 2026 06:22AM SI vs. AI: Super Intelligence Anomaly Outbreaks Trump’d by Clinton Legacy Tech (Veterans First for America)
View Newer Stories View Older Stories